AHA 2023 Insights: DAPA-MI - A Registry-Based Randomized Trial of Dapagliflozin in Patients With Acute Myocardial Infarction Without Diabetes or Heart Failure

162 views
November 21, 2023
0 Comments
Login to view comments. Click here to Login